GRMLW Greenland warrants eye mining project milestone as investors weigh opportunity against illiquidity risks Alector ALEC Stock Future Performance Expectations Buying Pressure 20260420 FFAI Faraday posts narrower Q4 2025 loss than analyst forecasts shares fall 20 percent amid investor disappointment ONB Old drops 263 after Q1 2026 EPS lands slightly below Wall Street consensus estimates Microsoft Corporation MSFT Amended OpenAI Partnership Eliminates Exclusive IP Access Alters Revenue Sharing Terms Why Victorias VSCO could be the turning point youve been waiting for Volatility Increases 20260508 Southern Company SO Mixed Analyst Price Target Adjustments Amid Utility Sector Outperformance eBay Rejects GameStops 71 Billion Takeover Bid as Neither Credible Nor Attractive Home Depot Surpasses Q1 2026 Estimates Maintains FullYear Outlook Nuwellis NUWE Q4 2025 Earnings EPS 150 Beats Estimates Analysis Reveals US Lacks Official Record of XiTrump Discussions on Taiwan India Markets Outlook Varun Goel Sees Opportunity in 4 Sectors Amid Geopolitical Tensions Kalshi Betting Odds Flop as Massie Upset in Primary Election Shakes Prediction Markets Bgin Blockchain Limited BGIN Reverses Higher Testing Key Resistance Zone Nio Shares Surge Following Launch of Chinas Largest Electric SUV PZZA Q1 2026 Earnings EPS Misses Estimates by 1155 Amid Cost Pressures Meta Tests AI Subscription Services as Zuckerberg Bets on NonAd Revenue XSLL Xsolla rolls out new developer monetization tools to support longterm revenue growth Why Lesaka Technologies LSAK earnings could be a turning point Q1 2026 Profit Surprises Salesforce Inc CRM Telco Vertical Growth Catalyst Emerges From MCE Systems New Advisory Board Hire TWLO Twilio reports 155 percent Q1 2026 EPS upside shares gain 131 percent amid favorable investor sentiment The industry tailwinds powering Jeffs Brands JFBR growth In Focus 20260508 CEPT CantorEquity leadership outlines longterm geographic expansion plans as core advisory segment stays steady amid broader market volatility MIRM Mirum Pharmaceuticals reports steep Q4 2025 EPS miss while shares post a small gain in todays trading